Gynecologic Cancers | Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers

published 1 month ago by Dr Neil Love

Featuring a discussion on the current and future role of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers with Dr David O’Malley, including the following topics: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — David M O’Malley, MD (0:00) Case: A woman in her late 20s with metastatic cervical cancer treated with tisotumab vedotin (21:45) Case: A woman in her mid-50s with metastatic cervical cancer treated with balstilimab on a clinical trial (25:20) Case: A woman in her 70s with MSI-high recurrent uterine cancer (26:06) CME information and select publications

more episodes from Research To Practice | Oncology Videos